Navigation Links
DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC

ting, sales and distribution of its products; or orBec® may not gain market acceptance; and others may develop technologies or products superior to orBec®. These and other factors are described from time to time in filings with the Securities and Exchange Commission, including, but not limited to, DOR's most recent reports on Form 10-QSB and Form 10-KSB. DOR assumes no obligation to update

or revise any forward-looking statements as a result of new information, future events, and changes in circumstances or for any other reason.


--------------------------------------------------------------------------------


Company Contact: Evan Myrianthopoulos Chief Financial Officer (786) 425-3848 http://www.dorbiopharma.com">www.dorbiopharma.com


SOURCE: DOR BioPharma, Inc.

--------------------------------------------------------------------------------


editorial@engelpub.com">http://promo.marketwire.com/cgi-bin/cwcd?5947=editorial@engelpub.com" border="0" width="5" height="5">

If you wish to be removed from this mailing list, please http://63.146.124.146/mw/cwunsub?ccwdid=E940ECC74456C012">click here.


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire-FirstCall/--Neurobiologic...todaythatitsboardofdirectorshasdeclaredanextraordi...bepaidonDecember9,2009tostockholdersofrecordasofNo...ndfollowsstockholderapprovalofthedissolutionofNTIp...ndanearlierextraordinarydividendof$0.75persharetha...
(Date:11/21/2009)...N, Nov. 21 An urgent need for new ...n the developing world has prompted a growing numb...on-profit product development partnerships (PDPs),...s noted today in a symposium at the 58th annual me... and Hygiene (ASTMH), these collaborations are ope...
(Date:11/20/2009)...la., Nov. 20 Unilens Vis...xchange: UVI), which develops, licenses, manufactu...ses, today reported its operating results for the ..., Net sales excluding royalty income, were $1,6... $1,761,526 reported in the previous year first qu...
Breaking Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Anesthesia Society Selects Sanford Brown Institute Instructor as Educator of the Year 61187 1Anesthesia Society Selects Sanford Brown Institute Instructor as Educator of the Year 61187 2Anesthesia Society Selects Sanford Brown Institute Instructor as Educator of the Year 61187 3Surgery Not Always Best for Narrowed Kidney Arteries 61185 1Surgery Not Always Best for Narrowed Kidney Arteries 61185 2Surgery Not Always Best for Narrowed Kidney Arteries 61185 3Tamiflu Resistant Swine Flu Found in Canadian Father 61183 1Tamiflu Resistant Swine Flu Found in Canadian Father 61183 2Tamiflu Resistant Swine Flu Found in Canadian Father 61183 3
... /PRNewswire-FirstCall/ --,Medivation, Inc. today ...30 a.m. Eastern time on Monday, June 11, to discus...ouble-blind,placebo-controlled Phase 2 clinical t...n Alzheimer,s disease. , Rachelle Doody, M.D., Ph....the 12-month results for the first time at a,scien...
... 7, 2007 - Clinical results from a,Phase II study ...che Society (AHS) annual meeting showed that MK-09...d peptide (CGRP),receptor antagonist, significantl...sing compared to placebo, and the relief was,susta...tolerated in,the study. Responses specific to othe...
Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5
(Date:11/23/2009)...ewswire/--James.G.Schwade,M.D.announcesthenewlyenh...attheCyberKnifeCenterofMiami,( www.cyberknifemiam...preciselytargetedintensedoseofradiationthatkillsca...fthetreatmentcanlastfrom30minutestoonehour,andisus...erKnifeTreatmentCenterintheSoutheasternU.S.,theMia...
(Date:11/23/2009)...fected within one year of starting to have sex, CD...hDay News) -- As many as one in four U.S. teenage ...), many infected soon after their first sexual enc...igh burden of STDs among teen girls reminds us tha...i L. Gottlieb, from the division of sexually trans...
(Date:11/23/2009)...ical College of Georgia is leading an initiative t...f patients with sickle cell disease. , Morehous...Florida are partners in the initiative that is enl...erve as "medical homes" for patients, changing how...m to the hospital and seeking better prevention an...
(Date:11/23/2009)...3/PRNewswire-FirstCall/--InstacareCorp.(OTCBulleti...of MD@Hand ,target=,_blank,title=, MD@Hand ,> MD@H...nk,title=, MD@Hand ,> MD@Hand ,> MD@Hand ,target=...nk,title=, MD@Hand ,target=,_blank,title=, MD@Hand...et=,_blank,title=, MD@Hand ,> MD@Hand ,> MD@Hand ...
(Date:11/23/2009)...3/PRNewswire/--Thanksgivingweekendmarksthe36thannu...,theClassicrepresentsthesportsmanshipandprideoftwo...leansandthoseinattendance. ,, Forthecrewofthene...omedowntimebeforetheyworktotestandlaunchabrandnews...uction,PettyOfficerClaudeBovellandtherestofthecrew...
Breaking Medicine News(10 mins):Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7Health News:Nothing Is Like Being There 2
...EXICO CITY, Feb. 17 Genomma Lab Internacional,S.A...cast: , , WHAT: Genomma Lab,s Fourth Quarte...bruary 18, 2009 at 11:00 A.M. Eastern, WHERE: ...., CONTACT: Melanie Carpenter, 212-406-3692, ...
...UBLIN, Ohio, Feb. 17 Cardinal Health today,announ...g Administration (FDA),on an amended consent decre..., Cardinal Health has operated under a consent...ended agreement, which is subject,to approval by t...
...y Olympic sport, Rodriguez would be banned at leas...Alex Rodriguez and Major League Baseball are showi... abuse," asserts former White House Drug Policy sp...rug Policy spokesman 1995-2001 and coordinated Whi...
...ical teams at The Johns Hopkins Hospital, Barnes-J...edical Center in Oklahoma City successfully comple...ino kidney transplant. All six donors one man and...rgeon at Johns Hopkins. , The procedure, kidney p...
... University,s Baker Institute has experts availabl...embryonic stem cell policy. , In January, Baker ...eleased policy recommendations on stem cell resear...a federal stem cell policy be developed. They enco...
... - Results demonstrate that GCC is the stronge...ectal cancer recurrence -, Ticker Symbol: CUR, ... /PRNewswire-FirstCall/ - The Journal of the Ameri...led patients demonstrating that guanylyl cyclase C...
Other Medicine News:Health News:Cardinal Health, FDA Amend Infusion Pump Consent Decree 2Health News:Rodriguez and Baseball: 'No Accountability'; 'Disgraceful' News Conference, Says Ex-White House Drug Spokesman Robert Weiner 2Health News:Johns Hopkins leads first 12-patient, multicenter 'domino donor' kidney transplant 2Health News:Major study on DiagnoCure's GCC biomarker published in Jama 2Health News:Major study on DiagnoCure's GCC biomarker published in Jama 3Health News:Major study on DiagnoCure's GCC biomarker published in Jama 4
Lasik Irrigator
Lasik Cannula - Daya
Anterior Chamber Maintainer
Irrigating Cannula - Rycroft
Medicine Products: